SB1454 Summary

• Reclassifies hydrocodone (dihydrocodeinone) combined with non-narcotic ingredients from Schedule II to Schedule III, limiting prescriptions to 30-day supplies with option for multiple prescriptions totaling up to 90 days.

• Establishes a Prescription Monitoring Program (PMP) requiring pharmacies to report controlled substance dispensing data to a central repository within 7 days, including patient information, drug details, prescriber/dispenser DEA numbers, and payment type.

• Creates a Prescription Monitoring Program Advisory Committee (PMPAC) comprised of licensed healthcare providers who prescribe or dispense controlled substances to review compliance with clinical practices and recommend scheduling changes.

• Allows prescribers, pharmacists, and Electronic Health Record/Pharmacy Record Systems to register for individual access to the PMP database to prevent duplicate prescriptions and overdoses.

• Exempts wholesale drug distributors regulated by the Department of Financial and Professional Regulation from storage, reporting, and security requirements for Schedule II hydrocodone products, treating them instead as Schedule III controlled substances.